Glucagon-like peptide 1 receptor agonists, including semaglutide, have increased in use and will continue to increase due to their effectiveness in weight loss.
Chau N. Truong, PhD
Advertisement
Articles by Chau N. Truong, PhD
Advertisement
Latest Updated Articles
Trends in Glucagon-Like Peptide 1 Receptor Agonist Prescribing PatternsPublished: August 15th 2025 | Updated:
Advertisement
Advertisement
Trending on AJMC
1
Dual JAK Inhibition Demonstrates Efficacy in Progressive Nonsegmental Vitiligo
2
FDA Approves Guselkumab for Pediatric Plaque Psoriasis, Active Psoriatic Arthritis
3
Nerandomilast a "No-Brainer" for First-Line Pulmonary Fibrosis Therapy: Justin M. Oldham, MD, PhD, MS
4
Evaluating Current Breast Cancer Care, Treatments: Lakshminarayanan Nandagopal, MD
5
